Calls Wyden Senate bill introduction a ‘critical step’

Industry Leaders Push for CBD Regulation

Today, ONE HEMP – a coalition of industry leaders committed to advancing regulatory standards for hemp-derived cannabinoid (CBD) products – hailed long overdue Congressional action toward the regulation of CBD as a dietary supplement with the introduction of the Cannabinoid Safety and Regulation Act (CSRA) by Senator Ron Wyden (OR). This legislative milestone builds upon the collaborative work between industry leaders, including Charlotte’s Web (TSX: CWEB) (OTCQX: CWBHF), which has been at the forefront of advancing FDA-level regulatory standards for more than a decade.

With the CBD industry experiencing rapid growth in recent years, regulation has been a pressing issue. The introduction of the CSRA is seen as a critical step in ensuring consumer safety and establishing clear guidelines for product quality and labeling.

Impact on Individuals

For consumers, the regulation of CBD as a dietary supplement means greater transparency and confidence in the products they are purchasing. With standardized regulations in place, individuals can make more informed decisions about the CBD products they use, knowing that they meet certain quality and safety standards.

Global Impact

On a global scale, the regulation of CBD in the United States sets a precedent for other countries to follow suit. As one of the largest markets for CBD products, the U.S. taking steps towards regulation can influence international standards and practices, leading to a more uniform approach to CBD regulation worldwide.

Conclusion

The introduction of the Cannabinoid Safety and Regulation Act by Senator Ron Wyden marks a significant milestone in the ongoing efforts to regulate CBD as a dietary supplement. With industry leaders and lawmakers coming together to address this issue, consumers can look forward to a safer and more standardized CBD market both domestically and internationally.